NIPPON CHEMIPHAR CO.,LTD. 4539Short Interest
No institution currently reports a short position of 0.5% or more in NIPPON CHEMIPHAR CO.,LTD. (4539). The last disclosure was on 2022-10-11 (Integrated Core Strategies (Asia) Pte. Ltd., 0.49%).
Estimated short interest
0.00%
±0.00%
Estimated position (shares)
0
As of 2026-11-18
Holders (0.5% or more)
0 firms
2 reports
Estimated short interest is the sum of positions of 0.5% or more reported within the past year. It also excludes 1 institutions that fell below 0.5%. How estimates are calculated
Disclosure History Summary
| First disclosure | 2022-10-07 |
|---|---|
| Latest disclosure | 2022-10-11 (Integrated Core Strategies (Asia) Pte. Ltd., 0.49%) |
| Reporting institutions | 1 firms (2 reports) |
| Peak estimated short interest | 0.50% (2022-10-07, 1 holders) |
Short Interest Trend Last 5 years, by institution, % of shares outstanding
Estimated short interest stacked by institution, counting only positions of 0.5% or more reported within the past year. The 1 largest current holders are colored and the rest are grouped as "Others". Hover over (or tap) a bar to see the breakdown.
- Integrated Core Strategies (Asia) Pte. Ltd.
0.00%
Estimated short interest, 2026-11-18
Current Positions by Short Seller Latest report of each holder
| Last report | Short seller | Position (shares) | Ratio | Change | Status |
|---|---|---|---|---|---|
| 2022-10-11 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 21,200 shares | Ratio 0.49% | ▼0.01% | Below 0.5% |
Disclosure History 2 in total
| Trade date | Short seller | Position (shares) | Ratio | Change | Note |
|---|---|---|---|---|---|
| 2022-10-11 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 21,200 shares | Ratio 0.49% | ▼0.01% | Below 0.5% |
| 2022-10-07 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 21,400 shares | Ratio 0.50% | ▲0.10% | — |
Shorted Stocks in the Same Industry Pharmaceutical
| Stock | Estimated ratio | Short sellers |
|---|---|---|
| GNI Group Ltd.2160 | 11.16% | 7 firms |
| Oncolys BioPharma Inc.4588 | 10.35% | 7 firms |
| HEALIOS K.K.4593 | 10.20% | 5 firms |
| SymBio Pharmaceuticals Limited4582 | 9.46% | 7 firms |
| Nxera Pharma Co.,Ltd.4565 | 7.35% | 5 firms |